Literature DB >> 12393631

N-terminal residues in murine P-selectin glycoprotein ligand-1 required for binding to murine P-selectin.

Lijun Xia1, Vishwanath Ramachandran, J Michael McDaniel, Kiem N Nguyen, Richard D Cummings, Rodger P McEver.   

Abstract

P-selectin binds to the N-terminal region of human P-selectin glycoprotein ligand-1 (PSGL-1). For optimal binding, this region requires sulfation on 3 tyrosines and specific core-2 O-glycosylation on a threonine. P-selectin is also thought to bind to the N terminus of murine PSGL-1, although it has a very different amino acid sequence than human PSGL-1. Murine PSGL-1 has potential sites for sulfation at Tyr13 and Tyr15 and for O-glycosylation at Thr14 and Thr17. We expressed murine PSGL-1 or constructs with substitutions of these residues in transfected Chinese hamster ovary cells that coexpressed the glycosyltransferases required for binding to P-selectin. The cells were assayed for binding to fluid-phase P-selectin and for tethering and rolling on P-selectin under flow. In both assays, substitution of Tyr13 or Thr17 markedly diminished, but did not eliminate, binding to P-selectin. In contrast, substitution of Tyr15 or Thr14 did not affect binding. Substitution of all 4 residues eliminated binding. Treatment of cells with chlorate, an inhibitor of sulfation, markedly reduced binding of wild-type PSGL-1 to P-selectin but did not further decrease binding of PSGL-1 with substitutions of both tyrosines. These data suggest that sulfation of Tyr13 and O-glycosylation of Thr17 are necessary for murine PSGL-1 to bind optimally to P-selectin. Because it uses only one tyrosine, murine PSGL-1 may rely more on other peptide components and O-glycosylation to bind to P-selectin than does human PSGL-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393631     DOI: 10.1182/blood-2001-11-0036

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

Review 1.  Biomechanics of leukocyte rolling.

Authors:  Prithu Sundd; Maria K Pospieszalska; Luthur Siu-Lun Cheung; Konstantinos Konstantopoulos; Klaus Ley
Journal:  Biorheology       Date:  2011       Impact factor: 1.875

Review 2.  Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.

Authors:  Alexander Zarbock; Klaus Ley; Rodger P McEver; Andrés Hidalgo
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

Review 3.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

4.  Molecular cloning and expression analysis of P-selectin glycoprotein ligand-1 from zebrafish (Danio rerio).

Authors:  Guijin Sun; Jie Pan; Kechun Liu; Sifeng Wang; Xue Wang; Ximin Wang
Journal:  Fish Physiol Biochem       Date:  2011-07-14       Impact factor: 2.794

Review 5.  Golgi glycosylation.

Authors:  Pamela Stanley
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

6.  Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.

Authors:  Thomas A Gerken; Oliver Jamison; Cynthia L Perrine; Jeremy C Collette; Helen Moinova; Lakshmeswari Ravi; Sanford D Markowitz; Wei Shen; Himatkumar Patel; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

7.  Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.

Authors:  Zhen-jia Liu; Yan-juan Yang; Lei Jiang; Ying-chun Xu; Ai-xia Wang; Guan-hua Du; Jin-ming Gao
Journal:  Acta Pharmacol Sin       Date:  2011-06-27       Impact factor: 6.150

8.  Targeting the PSGL-1 pathway for immune modulation.

Authors:  Roberto Tinoco; Linda M Bradley
Journal:  Immunotherapy       Date:  2017-09       Impact factor: 4.196

9.  Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.

Authors:  Won Ho Yang; Claudia Nussbaum; Prabhjit K Grewal; Jamey D Marth; Markus Sperandio
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

10.  Using CRISPR-Cas9 to quantify the contributions of O-glycans, N-glycans and Glycosphingolipids to human leukocyte-endothelium adhesion.

Authors:  Gino Stolfa; Nandini Mondal; Yuqi Zhu; Xinheng Yu; Alexander Buffone; Sriram Neelamegham
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.